Coronary artery disease: An inflammatory or infectious process

Basic Research in Cardiology, Supplement

Volumn 95, Issue 1, 2000, Pages

  Jahn, J ^a   Dalhoff, K ^a   Katus, H A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Coronary artery disease; Infection; Inflammation; Inflammatory parameters

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; BACTERIAL DNA; GLYCOSYLATED PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; ROXITHROMYCIN;

ATHEROSCLEROSIS; BACTERIUM ISOLATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE COURSE; HELICOBACTER PYLORI; HUMAN; HYPERCHOLESTEROLEMIA; INFECTION; INFLAMMATION; PATHOGENESIS; PROTEIN AGGREGATION; PROTEIN BLOOD LEVEL; REVIEW; RISK FACTOR;

ACUTE-PHASE PROTEINS; ANIMALS; BACTERIAL INFECTIONS; CORONARY DISEASE; DISEASE PROGRESSION; HUMANS; INFECTION; VASCULITIS; VIRUS DISEASES;

EID: 0034528976     PISSN: 01759418     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis
2. Randomised secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study
3. The inflammatory etiology of unstable angina
4. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplant human coronary arteries and colocalized with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages
5. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease
6. High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors
7. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty
8. Chronic infections and coronary heart disease: Is there a link?
9. Prospective study of hemostatic factors and incidence of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study
10. Rabbit model for Chlamydia pneumoniae infection
11. Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
12. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
13. Treatment with the antibiotic roxithromycin in patients with acute non-Q-wave coronary syndromes
14. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS Pilot Study. ROXIS Study Group
15. Pathophysiology and clinical significance of atherosclerotic plaque rupture
16. Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group
17. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line
18. Atherogenesis and inflammation
19. Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae
20. Vulnerable plaque: Pathobiology and clinical implications
21. Plasma protein acute-phase response in unstable angina is not induced by ischemic injury
22. Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients
23. Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction
24. Endovascular presence of viable Chlamydia pneumoniae is a common phenomen in coronary artery disease
25. Acute respiratory-tract infections and risk of first-time acute myocardial infarction
26. Murine models of Chlamydia pneumoniae infection and atherosclerosis
27. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse
28. Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells
29. Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes
30. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture
31. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy
32. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
33. Helicobacter pylori bacteriaemia
34. Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells
35. Previous cytomegalovirus infection and risk of coronary thrombotic events after stent placement
36. Seasonal pattern of acute myocardial infarction in the National Registry of Myocardial Infarction
37. Acetylsalicyclic acid and sodium salicylate inhibit LPS-induced NF-κβ/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-α) in human monocytes
38. Interaction of Chlamydia pneumoniae and human alveolar macrophages: Infection and inflammatory response
39. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
40. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
41. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators
42. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction
43. Aspirin and platelets: The antiplatelet action of aspirin and its role in thrombosis treatment and prophylaxis
44. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction
45. Anti-inflammatory drugs and their mechanism of action
46. Inflammatory status as a main determinant of outcome in patients with unstable angina, independent of coagulation activation and endothelial cell function
47. Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease
48. The role of heat shock proteins in protection and pathophysiology of the arterial wall
49. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy